Buy Nutropin Depot  Online

Buy Nutropin Depot Online [somatropin (rDNA origin) for injectable suspension], is a long-acting dosage form of recombinant human growth hormone (rhGH). Somatropin has 191 amino acid residues and a molecular weight of 22,125 daltons.

The amino acid sequence of the product is identical to that of pituitary-derived human growth hormone. The protein is synthesize by a specific laboratory strain of E.. coli as a precursor consisting of the rhGH molecule precede by the secretion signal from an E. coli protein.

Buy Growth Hormones Online

Moreover, This precursor is directed to the plasma membrane of the cell, Buy Drugs Online. The signal sequence is remove and the native protein, is secret into the periplasm so that the protein is folded appropriately as it is synthesized.

Somatropin is a highly purified preparation. Biological potency is determine using a cell proliferation bioassay.

The Nutropin Depot (somatropin rdna origin for inj) formulation consists of micronize particles of rhGH embedded in biocompatible, biodegradable polylactide-coglycolide (PLG) microspheres.

Order Nutropin Depot  Online

Nutropin Depot (somatropin rdna origin for inj) is packaged in vials as a sterile. White to off-white, preservative-free, free-flowing powder. Before administration, the powder is suspend in Diluent for Nutropin Depot (somatropin rdna origin for inj). (A sterile aqueous solution). Each 13.5 mg 3 cc single-use vial of Nutropin Depot (somatropin rdna origin for inj) contains 13.5 mg somatropin. 1.2 mg zinc acetate, 0.8 mg zinc carbonate, and 68.9 mg PLG.

Each 18 mg 3 cc single-use vial of Nutropin Depot (somatropin rdna origin for inj) contains 18 mg somatropin. 1.6 mg zinc acetate, 1.1 mg zinc carbonate, and 91.8 mg PLG.

Each 22.5 mg 3 cc single-use vial of Nutropin Depot (somatropin rdna origin for inj). contains 22.5 mg somatropin, 2.0 mg zinc acetate, 1.4 mg zinc carbonate, and 114.8 mg PLG.

Each dosage size contains an overage of rhGH microspheres to ensure delivery of labeled contents.

Each 1.5 mL single-use vial of Diluent for Nutropin Depot, (somatropin rdna origin for inj) contains 30 mg/mL carboxymethylcellulose sodium salt. 1 mg/mL polysorbate 20, 9 mg/mL sodium chloride, and sterile water for injection; pH 5.8-7.2.

Nutropin Depot® [somatropin (rDNA origin) for injectable suspension], is indicate for the long-term treatment of growth failure due to a lack of adequate endogenous GH secretion.

Considerations for use: –

As with any GH treatment, patients should be monitor closely throughout therapy for growth response to Nutropin Depot, (somatropin (rdna origin) for inj) .Failure to respond adequately requires careful assessment, as describe under DOSAGE AND ADMINISTRATION.

Patients for whom no discernible cause, is found should be consider for a course of treatment with a daily form of rhGH. Experience in patients who were treat with daily GH and switched to Nutropin Depot is limited.

DOSAGE AND ADMINISTRATION

Furthermore, The Nutropin Depot (somatropin (rdna origin) for inj) dosage and administration schedule, should be individualize for each patient. Response to GH therapy in pediatric patients tends to decrease over time.

However in pediatric patients, failure to increase growth rate. Particularly during the first year of therapy, suggests the need for close assessment of compliance and evaluation of other causes of growth failure. Such as hypothyroidism, undernutrition, and advanced bone age.

Once-Monthly Injection

– Again, It is recommend that an SC injection at a dosage of 1.5 mg/kg body weight be administer on the same day of each month.

Dosages above the recommend once-monthly regimen have not be studied in clinical trials. Note: subjects over 15 kg will require more than one injection per dose.

Twice-Monthly Injections

-It is recommend that an SC injection at a dosage of 0.75 mg/kg body weight be administer twice each month on the same days of each month (e.g., Days 1 and 15 of each month).

Finally, Dosages above the recommend twice-monthly regimen have not be studied in clinical trials. Note: subjects over 30 kg will require more than one injection per dose.

The table below indicates the require number of injections per dose.